Delayed Intensification Including Venetoclax and Bortezomib Prolongs Survival in Very High Risk Acute Lymphoblastic LeukaemiaJasmeet Sidhu, Shekhar Krishnan, Tanima Dey et al.|Blood|2023Cited by 1
Functional precision approach in patients with very high risk acute lymphoblastic leukaemia in India: a single-centre cohort studyJasmeet Sidhu, Vaskar Saha, Arijit Chakraborty et al.|Unknown|2026Cited by 0